So many regulatory bodies and governing bodies in pharmacy education: whims of my mind

PCI(Pharmacy Council Of India) and AICTE(All India Council for technical education) are the governing bodies in the pharmacy education , keeping in mind the compounding and dispensing as well as the technical aspects involved in Pharmaceutical Engineering .

Now with the advent of Pharm D course in pharmacy, which is clinically oriented 6 years course in pharmacy and the syllabus is designed such as  first 3 years are same as B.Pharm ( compounding and dispensing oriented) and next 2 years are same as MD Pharmacology (medically and clinically oriented) and 1 year of internship in an attached (minimum- 300 beded) hospital , one may expect MCI (medical council of India) to get into the thick of the things/matters.

As it requires an affiliation with a  hospital( minimum 300 beded), to get approval for an pharmaceutical institute from PCI to conduct the course , one must expect MCI(medical council of India) also to get involved as a regulatory and governing body.

PCI governs courses like : D.Pharm
                                         B.Pharm
                                        Pharm D and Pharm D(PB)

AICTE governs courses like : B.Pharm( jointly with PCI)
                                              M.Pharm

Now one must expect AICTE,PCI and MCI may jointly govern : Pharm D and Pharm D(PB)

But no, its not a rational thinking on my part. MCI will get involve only when the course is a medical one or may be when the professional doctor is dealing with a body part.
So, its fair enough that MCI is not involved into these matters.

                                             

PHARMACIST IN HEALTHCARE/PHARMACARE

PHARMACIST IN HEALTHCARE.

Unless Indian healthcare service and infrastructure is made inclusive of pharmacy and pharmacists service, there is no scope for pharmacist in healthcare

High-Risk Drugs

High-Risk Drugs

"High risk medicines are those medicines that have a high risk of causing significant patient harm or death when used in error.- Google search

Although errors may or may not be more common than with other medicines, the consequences of errors with these medicines can be more devastating" - Google search.

"A – Antimicrobials

P – Potassium and other electrolytes, psychotropic medications

I – Insulin

N – Narcotics, opioids and sedatives

C – Chemotherapeutic agents

H – Heparin and other anticoagulants

S – Safer systems (e.g. safe administration of liquid medications using oral syringes)

Methods to reduce error include strategies such as:

👉 improving access to information about these drugs

👉 limiting access to high risk medications

👉 using Tallman* lettering to differentiate high risk medications

using auxiliary labels and automated alerts

👉 standardising the prescription, storage, preparation, and administration of these products."

------------

*Tallman lettering:

1.acetaZOLAMIDE vs. acetoHEXAMIDE.

2. buPROPion vs. busPIRone.

3.chlorproMAZINE vs. chlorproPAMIDE.

5.clomiPHENE vs. clomiPRAMINE.

6. cycloSERINE vs. cycloSPORINE."

- Google search.

Pharmacists should recollect their lessons on Routes of Administration, Times of Administration, LASA drug names and Importance of Administration by Medical attendant or under Medical supervision.

Identifying and self regulating them by Retail Pharmacists looks highly imminent Now in Public Interest.

Attn. #Pharmacists &

          #DrugsInspectors